UBS 2024 Stock Market Outlook
UBS believes we’re still seeing the impact from the global pandemic and advises, “it’s time to build a plan, get in balance, and stay disciplined, yet agile.” | Read more: https://www.ubs.com/global/en/investor-relations/events/presentations.html
SPA Forecasts revenue growth
Spacetalk (ASX:SPA) delivers strong Mobile active subscribers and forecasts revenue growth, following strong Black Friday and Cyber Monday sell out performance representing a 58% growth on active Spacetalk Mobile subscribers | ASX announcement: https://spa.irmau.com/site/pdf/437cf872-cfee-42d6-9e3f-21229ba6f00a/Trading-Update-and-Revenue-Forecast.pdf #spacetalk
BIO Has initiated delivery in the UK and Ireland
Biome Australia (ASX:BIO) has launched Activated Probiotics® into the UK and Ireland as it looks to expand its operations into Europe. Activated Probiotics® low mood and sleep, bone health, iron malabsorption, mild eczema and IBS | https://announcements.asx.com.au/asxpdf/20240115/pdf/05zf6s623g45ys.pdf $BIO #UK
DigitalX’s (ASX:DCC) Bitcoin Fund rose 47.7% in Q4FY24
DigitalX’s (ASX:DCC) Bitcoin Fund rose 47.7% in Q4FY24 and management believes the bull market will continue. DCC’s announcement comes the day after the SEC approves the first BTC ETFs | https://buff.ly/3He1bqP #SEC #BTC #DCC #Bitcoin
AVITA Medical (ASX:AVH) signed an exclusive 5 year distribution agreement with Stedical Scientific
AVITA Medical (ASX:AVH) signed an exclusive five year distribution agreement with Stedical Scientific, to commercialise PermeaDerm® Biosynthetic Wound Matrix in the U.S. The matrix is cleared by the U.S. FDA and used for a variety of injuries | https://announcements.asx.com.au/asxpdf/20240111/pdf/05zbp446ftpyw0.pdf #FDA #PermeaDerm #AVH
Kali Metals (ASX:KM1) announces that preliminary exploration programs
Kali Metals (ASX:KM1) announces that preliminary exploration programs completed pre-IPO have identified and sampled lithium bearing pegmatites across multiple locations within the Higginsville District Scale tenement holding | ASX announcement: https://app.sharelinktechnologies.com/announcement/asx/c63d1992383d902bf2014e5a059dbbd9 #KM1
Silex Systems (ASX:SLX) announced the U.S. Department of Energy released the Request for Proposal
Silex Systems (ASX:SLX) announced the U.S. Department of Energy released the Request for Proposal for acquisition of High Assay Low Enriched Uranium. As a leader in laser uranium enrichment, management believes its eligible for part of the ~US$600m in funding up for grabs | https://announcements.asx.com.au/asxpdf/20240110/pdf/05z9kyqq248cy1.pdf $SLX #Uranium
Wildcat Resources Limited (ASX:WC8) announces the commencement of exploration activities for 2024
Wildcat Resources Limited (ASX:WC8) announces the commencement of exploration activities for 2024 at its Tabba Tabba Lithium Project. Undertaking this work is a necessary step to allow continued escalation of drilling capability in 2024 https://www.investi.com.au/api/announcements/wc8/f5056b27-51c.pdf #WC8 #lithium ASX:WC8 Share Price [stockdio-historical-chart symbol=”WC8″ stockExchange=”CHIX” width=”580″ height=”380″ motif=”financial” palette=”financial-light”]
Kali Metals (ASX:KM1) commenced trading on the ASX on January 8 2024
Kali Metals (ASX:KM1), an Australian resources company with a portfolio of lithium exploration projects in WA, NSW and VIC, commenced trading on the ASX on January 8 2024. The IPO was heavily oversubscribed and raised the maximum amount of $15 million https://app.sharelinktechnologies.com/announcement/asx/3d096ea12cb3d3e341804735de41e397
NEU Phase 2 trial shows significant improvements
Neuren Pharmaceuticals (ASX:NEU) announced top-line results from its Phase 2 clinical trial of NNZ-2591 in children with Phelan-McDermid syndrome. Significant improvement was observed by both clinicians and caregivers from treatment | ASX announcement: https://www.neurenpharma.com/pdf/f9ca13b8-b75f-4ff5-a5b7-1dcb75d547d6/P2-trial-shows-significant-improvements-in-PhelanMcDermid.pdf #shorts